Research Article
Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques
Table 3
Weighted normalized data of the SARS-CoV-2 diagnostic tests.
| Criteria | Importance weight | Max/Min | Naso/oropharyngeal swab PCR | Cell culture | CoV-19 antigen detection | CoV-19 antibody IgM | CoV-19 antibody IgG | Chest X-ray | Chest CT |
| No symptom-window period | VH | Max | 0.47 | 0.47 | 0.47 | 0.16 | 0.16 | 0.16 | 0.32 | Early stage | VH | Max | 0.47 | 0.47 | 0.47 | 0.47 | 0.16 | 0.16 | 0.47 | Active phase | VH | Max | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | 0.16 | 0.47 | Recurrent stage | VH | Max | 0.16 | 0.16 | 0.16 | 0.16 | 0.47 | 0.32 | 0.47 | Past infection | M | Max | 0.09 | 0.09 | 0.09 | 0.09 | 0.26 | 0.17 | 0.26 | Recovery stage | L | Max | 0.04 | 0.04 | 0.04 | 0.09 | 0.13 | 0.04 | 0.13 | Cost | M | Min | 0.09 | 0.09 | 0.26 | 0.09 | 0.09 | 0.09 | 0.09 | Accessibility | VH | Max | 0.47 | 0.16 | 0.16 | 0.47 | 0.47 | 0.47 | 0.47 | Usability | M | Max | 0.26 | 0.09 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | Equipment | M | Max | 0.17 | 0.09 | 0.26 | 0.09 | 0.09 | 0.09 | 0.26 | Education | M | Max | 0.17 | 0.09 | 0.09 | 0.26 | 0.26 | 0.17 | 0.26 | Sensitivity | H | Max | 0.13 | 0.39 | 0.13 | 0.13 | 0.13 | 0.26 | 0.39 | Specificity | H | Max | 0.39 | 0.39 | 0.13 | 0.26 | 0.26 | 0.26 | 0.39 | False positivity | VH | Min | 0.16 | 0.16 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 | False negativity | VH | Min | 0.47 | 0.16 | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
|
|
VH: very high; H: high; M: medium; L: low.
|